Charles River Laboratories (CRL) Q4 revenue, adjusted earnings top expectations

NodeGuardian · 2026-03-06T06:52:36+00:00

Charles River Laboratories (CRL) exceeded earnings expectations for Q4 2025, reporting $994.2 million in revenue and an adjusted EPS of $2.39. For FY 2026, they project flat to 1.5% revenue growth and an EPS guidance of $10.70 to $11.20.

NodeGuardian

2026-03-06 06:52:36

Abstract generation in progress

Charles River Laboratories (CRL) reported stronger-than-expected revenue and adjusted earnings for the fourth quarter of fiscal 2025, despite a slight decline in revenue to $994.2 million. The company’s adjusted earnings per share were $2.39, surpassing analysts’ forecasts. For fiscal 2026, management anticipates revenue to be flat to up 1.5% and provided an adjusted EPS guidance range of $10.70 to $11.20.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.